Table 6.
Hyaluronidase Practical Aspects
| Consent | Mandatory informed consent: aesthetic use may be off-label; check country-specific recommendations | |
| Diluent | Saline, bacteriostatic saline, water | |
| Dilution | Eg 1–10 mL/1500 IU | |
| Timing | Onset of action | Immediate |
| T ½ | 2 minutes | |
| Duration of action | 48 hours | |
| Recovery time endogenous HA | 48 hours | |
| Serum half-life | 2 ½ minutes | |
| Dosage | Nodules | 4–40 IU/0.1 mL HA |
| Vascular events | HDPH: 500 −1500 IU hourly | |
| Endogenous HA degradation | Higher than standard treatment doses | |
| Technical aspects | Massage to increase contact Consider cannula to minimize eventual bruising |
|